Insider Selling: Homology Medicines (BATS:FIXX) CEO Sells 9,845 Shares of Stock

Homology Medicines, Inc. (BATS:FIXX) CEO Jodie Pope Morrison sold 9,845 shares of the business’s stock in a transaction that occurred on Tuesday, August 25th. The stock was sold at an average price of $16.56, for a total transaction of $163,033.20. Following the sale, the chief executive officer directly owned 343,259 shares in the company, valued at $5,684,369.04. The trade was a 2.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Homology Medicines Stock Up 0.1%

BATS FIXX traded up $0.02 on Thursday, hitting $12.90. The company’s stock had a trading volume of 978 shares.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.